Q & A

Hardman and Co’s Mark Thomas discusses Fidelity Japan Trust plc in this exclusive interview with DirectorsTalk.

SP Angel’s Vadim Alexandre discusses N4 Pharma plc in this exclusive interview with DirectorsTalk.

Jarvis Securities’ Jolyon Head discusses interim results, significant cash on the balance sheet, financial performance over the next six months and whether there are any significant changes going forward in...

Renold’s Robert Purcell discusses final results, performance during the pandemic, growth in order books, their Chinese factory, and the outlook for the company in this exclusive interview with DirectorsTalk.

Helium One’s David Minchin discusses Helium One’s strategy, why helium is so important, drilling programme, the recent gas show and what’s next for the company in this exclusive interview with...

Symphony Environmental’s Ian Bristow discusss receiving FDA approval for its d2p technology & what this means for the company, other regions being targeted and what investors can expect over the...

Ilika’s Steve Boydell discusses their successful institutional & retail placings, what the fund will be used for, total share allocation, deadline, and the excess application facility in this exclusive interview...

Cerillion’s Louis Hall discusses operator investment, what makes 5G such a significant step forward, how the use cases impact on telecom software, how the pandemic affected investment in telecoms software...

Open Orphan’s Cathal Friel discusses progress on a number of fronts in this exclusive interview with DirectorsTalk.

Dekel Agri-Vision’s Lincoln Moore discusses their strong first half, palm oil prices, how they’re tracking against Arden Partners’ numbers and what investors can expect over the coming months in this...